Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PAVmed Inc. Director's Dealing 2024

Jan 30, 2024

35221_dirs_2024-01-30_86ad31cc-a658-4ab3-9ef0-445319b58914.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lucid Diagnostics Inc. (LUCD)
CIK: 0001799011
Period of Report: 2024-01-26

Reporting Person: PAVmed Inc. (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-01-26 Common Stock J 3331771 $1.4033 Acquired 34634191 Direct

Footnotes

F1: Issuance of common stock by the Issuer to the Reporting Person in satisfaction of a commercial agreement.